Biomarkers
Source-reviewed
LN Evidence Score
N/A
Pending review
LN Claim Risk Score
N/A
Pending review
LN Commercial Maturity Score
N/A
Pending review
LN Clinic Transparency Score
N/A
Pending review
Biomarkers
Source-reviewed draft
Umbrella biomarker-signal record covering IMM-AGE, iAge, IMMAX, sc-ImmuAging, and related immune-clock approaches as distinct research-stage signals. It compares model-development, association, and trial-readiness evidence while keeping diagnostic, consumer-test, and clinical-utility claims out of scope.
LN Evidence Score
3
of 5
LN Claim Risk Score
4
of 5
LN Commercial Maturity Score
0
of 5
LN Clinic Transparency Score
0
of 5
Biomarkers
Sample / unverified
Research-stage immune and inflammatory aging signal category. Staging draft; not diagnostic, prescriptive, or individually actionable.
LN Evidence Score
2
of 5
LN Claim Risk Score
3
of 5
LN Commercial Maturity Score
2
of 5
LN Clinic Transparency Score
0
of 5
Biomarkers
Source-reviewed draft
Research-stage biomarker category covering DNA methylation clocks and pace-of-aging measures. Staging draft; not diagnostic or prescriptive.
LN Evidence Score
3
of 5
LN Claim Risk Score
3
of 5
LN Commercial Maturity Score
2
of 5
LN Clinic Transparency Score
0
of 5